Text Size

Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only

This study has been completed.
Sponsor:
Collaborators:
University of Toronto
Hamilton Health Sciences Corporation
Ontario Ministry of Health and Long Term Care
Information provided by:
West Park Healthcare Centre
ClinicalTrials.gov Identifier:
NCT00546299
First received: October 17, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
  Purpose

Several studies have described the use of supplemental oxygen during exertion or activities of daily living (ambulatory oxygen) in study populations that have different characteristics. This report, based on specialized randomized controlled trials, characterizes ambulatory gas usage among patients with COPD who experience low oxygen levels during activities.


Condition Intervention
Chronic Obstructive Pulmonary Disease
 Drug: oxygen

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Ambulatory Gas Usage in Patients With COPD and Exertional Hypoxemia

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by West Park Healthcare Centre:

Primary Outcome Measures:
  • gas usage [ Time Frame: 2 ]

Enrollment: 27
Study Start Date: February 2003
Study Completion Date: December 2005
Intervention Details:
    Drug: oxygen
    cylinder and concentrator, dosage to maintain SpO2 above 92%, used during exertion
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of COPD
  • dyspnea limiting daily activities
  • desaturation less than or equal to 88% for 2 continuous minutes during a room air six-minute walk test

Exclusion Criteria:

  • less than or equal to 18 years old
  • those who met criteria for mortality reduction with long-term oxygen
  • those who received oxygen for palliative care or isolated nocturnal hypoxemia
  • those unable to complete the questionnaires or provide informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00546299

Sponsors and Collaborators
West Park Healthcare Centre
University of Toronto
Hamilton Health Sciences Corporation
Ontario Ministry of Health and Long Term Care
Investigators
Study Director: Roger Goldstein, MD Respiratory Rehabilitation, West Park Healthcare Centre
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00546299     History of Changes
Other Study ID Numbers: 8-42361
Study First Received: October 17, 2007
Last Updated: October 17, 2007
Health Authority: Canada: Ministry of Health & Long Term Care, Ontario

Keywords provided by West Park Healthcare Centre:
Ambulatory oxygen therapy
COPD
exertional hypoxemia

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on June 17, 2013